Colm Murphy, general plant manager of Anpharm, a key European production site for the Servier group, highlights major investments in recent years, such as the state-of-the-art QC Lab, and his strategy to increase the plant’s exports. Additionally, he discusses the growing importance of the company’s CDMO activities and the steps taken to remain cost competitive, while delivering world-class quality products.
What are the major investments into the plant over the last few years?
"The Polish site will never be as large as the French or Irish Servier production sites, however we are very agile and help alleviate pressure on the company’s manufacturing network."
